0000891293-12-000022.txt : 20120420 0000891293-12-000022.hdr.sgml : 20120420 20120420180046 ACCESSION NUMBER: 0000891293-12-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120419 FILED AS OF DATE: 20120420 DATE AS OF CHANGE: 20120420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PHILIPS CRAIG CENTRAL INDEX KEY: 0001441383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 12771717 MAIL ADDRESS: STREET 1: 501 ELLIOTT AVE W., SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELL THERAPEUTICS INC CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 ELLIOTT AVE W STREET 2: STE 400 CITY: SEATTLE STATE: WA ZIP: 98119 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 501 ELLIOTT AVE W STREET 2: STE 400 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 primary_doc.xml PRIMARY DOCUMENT X0305 4 2012-04-19 0 0000891293 CELL THERAPEUTICS INC CTIC 0001441383 PHILIPS CRAIG 501 ELLIOTT AVE W., SUITE 400 SEATTLE WA 98119 0 1 0 0 President Common Stock 2012-04-19 4 S 0 500 1.191 D 3980341 D Common Stock 2012-04-19 4 S 0 9300 1.2 D 3971041 D Common Stock 2012-04-19 4 S 0 600 1.205 D 3970441 D Common Stock 2012-04-19 4 S 0 1600 1.21 D 3968841 D The sale was effected pursuant to a Rule 10b5-1 trading plan. Louis A. Bianco, Attorney-in-fact for Craig Philips 2012-04-20